Despite significant advancements in the management of pulmonary hypertension (PH), several unmet needs remain. Patients continue to face challenges related to symptom control, mental health, and the long-term impacts of both the disease and its treatments. Additionally, there is a critical need for improved global access to care, multidimensional support, and advocacy. In this podcast episode, Dr. Jean Elwing and Dr. Oksana Shlobin discuss these gaps by focusing on the latest updates from the 7th World Symposium on Pulmonary Hypertension (WSPH), offering insights into the latest clinical classifications, risk stratifications, and treatment strategies.

This podcast aims to enhance clinical practice by presenting key research findings, new treatment algorithms, and the implications of emerging therapies. The discussion will include advances in multimodality imaging, genetics, and right ventricular function, highlighting how these innovations improve PH diagnosis and patient management. Through an expert-led presentation and interactive Q&A session, participants will gain a comprehensive understanding of how these developments will shape future research and personalized care for PH patients.

Launch Date: November 19, 2024

Release Date: November 19, 2024

Expiration Date: October 31, 2025

FACULTY

Jean Elwing, MD

Professor of Medicine

Director, Pulmonary Hypertension Program

University of Cincinnati

Oksana Shlobin, MD

Medical Director, Pulmonary Hypertension Program

Director of Education and Outreach, Advanced Lung Disease Program

Inova Fairfax Hospital

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/talking-pah-updates-from-the-7th-world-symposium-on-pulmonary-hypertension-1